Related references
Note: Only part of the references are listed.Human papillomavirus E6 and E7: What remains?
Arushi Vats et al.
TUMOUR VIRUS RESEARCH (2021)
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
Arnaud John Kombe Kombe et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Persistent Human Papillomavirus Infection
Ashley N. Della Fera et al.
VIRUSES-BASEL (2021)
Acquisition of a phospho-acceptor site enhances HPV E6 PDZ-binding motif functional promiscuity
Vanessa Sarabia-Vega et al.
JOURNAL OF GENERAL VIROLOGY (2020)
Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes
Irene Lo Cigno et al.
JOURNAL OF VIROLOGY (2020)
Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance
Matthew L. Scott et al.
JOURNAL OF VIROLOGY (2020)
Human papillomavirus oncoproteins and post-translational modifications: generating multifunctional hubs for overriding cellular homeostasis
Om Basukala et al.
BIOLOGICAL CHEMISTRY (2020)
A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation
Joshua Hatterschide et al.
JOURNAL OF VIROLOGY (2020)
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
Shuling Ren et al.
ONCOGENE (2020)
PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis
Joshua Hatterschide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells
Om Basukala et al.
PLOS PATHOGENS (2019)
Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus
Jiawei Zhao et al.
NATURE COMMUNICATIONS (2019)
Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response
Justine Sitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Identification of E6AP-independent degradation targets of HPV E6
Arushi Vats et al.
JOURNAL OF GENERAL VIROLOGY (2019)
Refining our understanding of cervical neoplasia and its cellular origins
John Doorbar et al.
PAPILLOMAVIRUS RESEARCH (2019)
The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling
Cindy Chiang et al.
JOURNAL OF VIROLOGY (2018)
The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity
Jayashree Thatte et al.
JOURNAL OF VIROLOGY (2018)
Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes
Matthew L. Scott et al.
VIROLOGY (2018)
KDM5 histone demethylases repress immune response via suppression of STING
Lizhen Wu et al.
PLOS BIOLOGY (2018)
The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
Miren Taberna et al.
FRONTIERS IN ONCOLOGY (2018)
p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling
Kirtiman Srivastava et al.
ONCOTARGET (2017)
Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma
Ge Gao et al.
GENES CHROMOSOMES & CANCER (2017)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch
Christian Kranjec et al.
JOURNAL OF PATHOLOGY (2017)
High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway
Nicholas A. Wallace et al.
JOURNAL OF VIROLOGY (2017)
The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7
Anita Szalmas et al.
JOURNAL OF VIROLOGY (2017)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift?
Iain M. Morgan et al.
VIRUSES-BASEL (2017)
Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins
Mallory E. Harden et al.
MBIO (2017)
Mitotic control of human papillomavirus genome-containing cells is regulated by the function of the PDZ-binding motif of the E6 oncoprotein
Elizabeth K. Marsh et al.
ONCOTARGET (2017)
Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness
Nicole Brimer et al.
PLOS PATHOGENS (2017)
KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress
David R. Soto et al.
PLOS PATHOGENS (2017)
The role of integration in oncogenic progression of HPV-associated cancers
Alison A. McBride et al.
PLOS PATHOGENS (2017)
Cdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells
Hanxiang Chen et al.
SCIENTIFIC REPORTS (2017)
Mechanisms and strategies of papillomavirus replication
Alison A. McBride
BIOLOGICAL CHEMISTRY (2017)
Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes
Yuki Yoshimatsu et al.
CANCER SCIENCE (2017)
Role of Cdc6 in re-replication in cells expressing human papillomavirus E7 oncogene
Xueli Fan et al.
CARCINOGENESIS (2016)
Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements
Masahiko Ajiro et al.
JOURNAL OF VIROLOGY (2016)
High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation
Elizabeth A. White et al.
MBIO (2016)
Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways
Ketaki Ganti et al.
PLOS PATHOGENS (2016)
Analysis of Multiple HPV E6 PDZ Interactions Defines Type-Specific PDZ Fingerprints That Predict Oncogenic Potential
Miranda Thomas et al.
PLOS PATHOGENS (2016)
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Martyn Plummer et al.
LANCET GLOBAL HEALTH (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?
Claire D. James et al.
PATHOGENS (2016)
Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells
Fang Li et al.
MEDICAL ONCOLOGY (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway
Laura Lau et al.
SCIENCE (2015)
E6 E7, a Novel Splice Isoform Protein of Human Papillomavirus 16, Stabilizes Viral E6 and E7 Oncoproteins via HSP90 and GRP78
Masahiko Ajiro et al.
MBIO (2015)
HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
Danilo Ranieri et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cancer-Causing Human Papillomavirus E6 Proteins Display Major Differences in the Phospho-Regulation of Their PDZ Interactions
Siaw Shi Boon et al.
JOURNAL OF VIROLOGY (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer
N. Wang et al.
BRITISH JOURNAL OF CANCER (2014)
High-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation
Vaibhav Chand et al.
CARCINOGENESIS (2014)
Matrix Metalloproteinase-14 Expression and Its Prognostic Value in Cervical Carcinoma
Huayi Wang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Variable transcript expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer
Sung Ho Um et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Human Papillomavirus E7 Oncoprotein Increases Production of the Anti-Inflammatory Interleukin-18 Binding Protein in Keratinocytes
Kathryn H. Richards et al.
JOURNAL OF VIROLOGY (2014)
Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different
Rosemarie Krupar et al.
VIRCHOWS ARCHIV (2014)
The Heterogeneous Structural Behavior of E7 from HPV16 Revealed by NMR Spectroscopy
Eduardo O. Calcada et al.
CHEMBIOCHEM (2013)
Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment
Chunxia Ren et al.
EUROPEAN JOURNAL OF CANCER (2013)
The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter
Uzma A. Hasan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
High-Risk Human Papillomavirus E6 Oncoproteins Interact with 14-3-3ζ in a PDZ Binding Motif-Dependent Manner
Siaw Shi Boon et al.
JOURNAL OF VIROLOGY (2013)
NFX1-123 and Human Papillomavirus 16E6 Increase Notch Expression in Keratinocytes
Portia A. Vliet-Gregg et al.
JOURNAL OF VIROLOGY (2013)
HPV16 Oncoproteins Promote Cervical Cancer Invasiveness by Upregulating Specific Matrix Metalloproteinases
Jittranan Kaewprag et al.
PLOS ONE (2013)
Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines
Margaret E. McLaughlin-Drubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins
Katia Zanier et al.
SCIENCE (2013)
Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis
Yueyang Yu et al.
VIROLOGY (2013)
Proteomic approaches to the study of papillomavirus-host interactions
Elizabeth A. White et al.
VIROLOGY (2013)
Biochemical and Functional Interactions of Human Papillomavirus Proteins with Polycomb Group Proteins
Margaret E. McLaughlin-Drubin et al.
VIRUSES-BASEL (2013)
The HPV16 E6 Oncoprotein Causes Prolonged Receptor Protein Tyrosine Kinase Signaling and Enhances Internalization of Phosphorylated Receptor Species
Jennifer M. Spangle et al.
PLOS PATHOGENS (2013)
Human papillomaviruses and the specificity of PDZ domain targeting
David Pim et al.
FEBS JOURNAL (2012)
Cdc6 Protein Activates p27KIP1-bound Cdk2 Protein Only after the Bound p27 Protein Undergoes C-terminal Phosphorylation
Baasanjav Uranbileg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Conserved Region 3 of Human Papillomavirus 16 E7 Contributes to Deregulation of the Retinoblastoma Tumor Suppressor
Biljana Todorovic et al.
JOURNAL OF VIROLOGY (2012)
Quantitative Measurement of Human Papillomavirus Type 16 E5 Oncoprotein Levels in Epithelial Cell Lines by Mass Spectrometry
Ziad Sahab et al.
JOURNAL OF VIROLOGY (2012)
The E6 Oncoprotein from HPV16 Enhances the Canonical Wnt/β-Catenin Pathway in Skin Epidermis In Vivo
Jose Bonilla-Delgado et al.
MOLECULAR CANCER RESEARCH (2012)
DNA methylation and microRNA dysregulation in cancer
Hiromu Suzuki et al.
MOLECULAR ONCOLOGY (2012)
Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling
N. Brimer et al.
ONCOGENE (2012)
Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
Zarina J. D'Costa et al.
PLOS ONE (2012)
Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling
Min Jie Alvin Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Solution Structure Analysis of the HPV16 E6 Oncoprotein Reveals a Self-Association Mechanism Required for E6-Mediated Degradation of p53
Katia Zanier et al.
STRUCTURE (2012)
Human papillomavirus type 16 E7 oncoprotein engages but does not abrogate the mitotic spindle assembly checkpoint
Yueyang Yu et al.
VIROLOGY (2012)
Physiology and pathophysiology of matrix metalloproteases
T. Klein et al.
AMINO ACIDS (2011)
PDZ domains: the building blocks regulating tumorigenesis
Vanitha Krishna Subbaiah et al.
BIOCHEMICAL JOURNAL (2011)
Role of the endothelin axis and its antagonists in the treatment of cancer
A. Bagnato et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Human Papillomavirus E7 Enhances Hypoxia-Inducible Factor 1-Mediated Transcription by Inhibiting Binding of Histone Deacetylases
Jason M. Bodily et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Human Papillomavirus (HPV) E7 Induces Prolonged G2 following S Phase Reentry in Differentiated Human Keratinocytes
N. Sanjib Banerjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Systematic Analysis of the Amino Acid Residues of Human Papillomavirus Type 16 E7 Conserved Region 3 Involved in Dimerization and Transformation
Biljana Todorovic et al.
JOURNAL OF VIROLOGY (2011)
High-Risk Human Papillomaviruses Repress Constitutive Kappa Interferon Transcription via E6 To Prevent Pathogen Recognition Receptor and Antiviral-Gene Expression
Jeanette Reiser et al.
JOURNAL OF VIROLOGY (2011)
The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression
Nina Korzeniewski et al.
MOLECULAR CANCER (2011)
HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic
F. Belleudi et al.
ONCOGENE (2011)
Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming
Margaret E. McLaughlin-Drubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance
Lietta Nicolaides et al.
VIROLOGY (2011)
A Role for HPV16 E5 in Cervical Carcinogenesis
John P. Maufort et al.
CANCER RESEARCH (2010)
Human papillomavirus type 16 E5 protein inhibits hydrogen peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells
Jung-Min Oh et al.
CARCINOGENESIS (2010)
Par3 Controls Epithelial Spindle Orientation by aPKC-Mediated Phosphorylation of Apical Pins
Yi Hao et al.
CURRENT BIOLOGY (2010)
All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization
Marc S. Cortese et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Robust control of mitotic spindle orientation in the developing epidermis
Nicholas D. Poulson et al.
JOURNAL OF CELL BIOLOGY (2010)
Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain
Silvia Barbaresi et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Loss of Epidermal Langerhans Cells Occurs in Human Papillomavirus α, γ, and μ but Not β Genus Infections
Cheng Mee Leong et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
The Human Papillomavirus Type 16 E5 Oncoprotein Inhibits Epidermal Growth Factor Trafficking Independently of Endosome Acidification
Frank A. Suprynowicz et al.
JOURNAL OF VIROLOGY (2010)
CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
Shiho Miura et al.
JOURNAL OF VIROLOGY (2010)
Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins
Marta Melar-New et al.
JOURNAL OF VIROLOGY (2010)
The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis
Jennifer M. Spangle et al.
JOURNAL OF VIROLOGY (2010)
Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-Positive Oropharyngeal Squamous Carcinoma Cells
Theodore Rampias et al.
MOLECULAR CANCER RESEARCH (2010)
Destabilization of TIP60 by Human Papillomavirus E6 Results in Attenuation of TIP60-Dependent Transcriptional Regulation and Apoptotic Pathway
Sudhakar Jha et al.
MOLECULAR CELL (2010)
Low- and high-risk human papillomavirus E7 proteins regulate p130 differently
Lisa Barrow-Laing et al.
VIROLOGY (2010)
HPV16 E6 augments Wnt signaling in an E6AP-dependent manner
Hava Lichtig et al.
VIROLOGY (2010)
The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27Kip1
Adolfo Pedroza-Saavedra et al.
VIROLOGY (2010)
HPV-16 E5 down-regulates expression of surface HLA class I by CD8 T cells
M. S. Campo et al.
VIROLOGY (2010)
Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin
Nicole Spardy et al.
CANCER RESEARCH (2009)
Identification of an Aurora-A/PinsLINKER/Dlg Spindle Orientation Pathway using Induced Cell Polarity in S2 Cells
Christopher A. Johnston et al.
CELL (2009)
Human Papillomavirus E7 Protein Deregulates Mitosis via an Association with Nuclear Mitotic Apparatus Protein 1
Christine L. Nguyen et al.
JOURNAL OF VIROLOGY (2009)
Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion
Lulin Hu et al.
VIROLOGY (2009)
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent
Vjekoslav Tomaic et al.
VIROLOGY (2009)
HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition
Karin Hellner et al.
VIROLOGY (2009)
E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway
Adriana Contreras-Paredes et al.
VIROLOGY (2009)
Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses
Meelis Kadaja et al.
PLOS PATHOGENS (2009)
Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation
Cary A. Moody et al.
PLOS PATHOGENS (2009)
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Adrian P. Bracken et al.
NATURE REVIEWS CANCER (2009)
Delocalization of the Microtubule Motor Dynein from Mitotic Spindles by the Human Papillomavirus E7 Oncoprotein Is Not Sufficient for Induction of Multipolar Mitoses
Christine L. Nguyen et al.
CANCER RESEARCH (2008)
Activation of the Enhancer of Zeste Homologue 2 Gene by the Human Papillomavirus E7 Oncoprotein
Daniela Holland et al.
CANCER RESEARCH (2008)
E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6
Li Zheng et al.
GENES TO CELLS (2008)
Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis
Jasenka Mazibrada et al.
GYNECOLOGIC ONCOLOGY (2008)
Human papillomavirus type 16 E7 oncoprotein associates with E2F6
Margaret E. McLaughlin-Drubin et al.
JOURNAL OF VIROLOGY (2008)
NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes
Mei Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Evolving immunosuppressive microenvironment during human cervical carcinogenesis
A. Kobayashi et al.
MUCOSAL IMMUNOLOGY (2008)
A complex barcode underlies the heterogeneous response of p53 to stress
Fiona Murray-Zmijewski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Cell polarity proteins: common targets for tumorigenic human viruses
R. T. Javier
ONCOGENE (2008)
Human papillomaviruses, cervical cancer and cell polarity
M. Thomas et al.
ONCOGENE (2008)
ATP-dependent activation of p21WAF1/CIP1-associated Cdk2 by Cdc6
Qiuming Kan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
Christine L. Nguyen et al.
VIROLOGY (2008)
Plasticity in tumor-promoting inflammation: Impairment of macrophage recruitment evokes a compensatory neutrophil response
Jessica Pahler et al.
NEOPLASIA (2008)
Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression
N. Kivi et al.
ONCOGENE (2008)
New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
K. Yamato et al.
CANCER GENE THERAPY (2008)
Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component γ-tubulin
Christine L. Nguyen et al.
JOURNAL OF VIROLOGY (2007)
The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells
Myriam Gruener et al.
VIROLOGY JOURNAL (2007)
Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior
W. Chen et al.
VIROLOGY (2007)
HAda3 regulates p14ARF-induced p53 acetylation and senescence
P. Sekaric et al.
ONCOGENE (2007)
The N-terminal module of HPV16 E7 is an intrinsically disordered domain that confers conformational and recognition plasticity to the oncoprotein
Maria M. Garcia-Alai et al.
BIOCHEMISTRY (2007)
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor
KyungWon Huh et al.
JOURNAL OF VIROLOGY (2007)
Nitrative and oxidative DNA damage in cervical intraepithelial neoplasia associated with human papilloma virus infection
Yusuke Hiraku et al.
CANCER SCIENCE (2007)
The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity
Maria Filippova et al.
JOURNAL OF VIROLOGY (2007)
NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells
Rachel A. Katzenellenbogen et al.
JOURNAL OF VIROLOGY (2007)
Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression- : Clinicopathological correlation
Luciano S. Hammes et al.
GYNECOLOGIC ONCOLOGY (2007)
Viral oncoproteins target the DNA methyltransferases
W. A. Burgers et al.
ONCOGENE (2007)
Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein
Nicole Brimer et al.
VIROLOGY (2007)
The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins
Petric Kuballa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Bovine papillomavirus E7 oncoprotein inhibits anoikis
Joseph DeMasi et al.
JOURNAL OF VIROLOGY (2007)
E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain
G. Hossein Ashrafi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300
Michael A. James et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7
O. Ohlenschlaeger et al.
ONCOGENE (2006)
Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein
M. Vogt et al.
ONCOGENE (2006)
Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein
Craig W. Menges et al.
CANCER RESEARCH (2006)
The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16-or type 18-positive cervical cancer cell lines via translation reinitiation
S Tang et al.
JOURNAL OF VIROLOGY (2006)
Structural and functional analysis of E6 oncoprotein:: Insights in the molecular pathways of human papillomavirus-mediated pathogenesis
Y Nominé et al.
MOLECULAR CELL (2006)
Chaperone holdase activity of human papillomavirus E7 oncoprotein
LG Alonso et al.
BIOCHEMISTRY (2006)
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation
BY Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor
X Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activating E2Fs mediate transcriptional regulation of human E2F6 repressor
TE Lyons et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A
D Pim et al.
ONCOGENE (2005)
Asymmetric cell divisions promote stratification and differentiation of mammalian skin
T Lechler et al.
NATURE (2005)
The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins
M Thomas et al.
ONCOGENE (2005)
Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding
J DeMasi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600
KW Huh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion
YL Zhai et al.
CANCER RESEARCH (2005)
Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene
SMG Williams et al.
CANCER RESEARCH (2005)
Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53
A Hengstermann et al.
JOURNAL OF VIROLOGY (2005)
The carcinogenicity of human papillornavirus types reflects viral evolution
M Schiffman et al.
VIROLOGY (2005)
Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation
SC Fausch et al.
JOURNAL OF IMMUNOLOGY (2005)
HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs
MS Longworth et al.
EMBO JOURNAL (2005)
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
KE de Visser et al.
CANCER CELL (2005)
HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes
BY Zhang et al.
ONCOGENE (2005)
The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein
XF Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation
A Kuzmichev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation
MC Thomas et al.
MOLECULAR CELL (2005)
E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I
GH Ashrafi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Molecular mechanisms of E2F-dependent activation and pRB-mediated repression
MV Frolov et al.
JOURNAL OF CELL SCIENCE (2004)
Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors
E Toussaint-Smith et al.
ONCOGENE (2004)
The HPV 16 E7 viral oncoprotein self-assembles into defined spherical oligomers
LG Alonso et al.
BIOCHEMISTRY (2004)
Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex
L Gewin et al.
GENES & DEVELOPMENT (2004)
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis
E Giraudo et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin
ZM Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth
IG Bravo et al.
JOURNAL OF VIROLOGY (2004)
Endothelin-1 could be one of the targets of psoriasis therapy
P Simeone et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis
M Filippova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mechanisms of human papillomavirus-induced oncogenesis
K Münger et al.
JOURNAL OF VIROLOGY (2004)
Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31
CH Lee et al.
JOURNAL OF VIROLOGY (2004)
The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures
K Kabsch et al.
INTERVIROLOGY (2004)
Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members
S Duensing et al.
JOURNAL OF VIROLOGY (2003)
Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7
WX He et al.
JOURNAL OF VIROLOGY (2003)
siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells
K Butz et al.
ONCOGENE (2003)
Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression
HR McMurray et al.
JOURNAL OF VIROLOGY (2003)
Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions
CE Gieswein et al.
VIROLOGY (2003)
Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin
K Matthews et al.
JOURNAL OF VIROLOGY (2003)
Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16
DH Yang et al.
PROTEIN EXPRESSION AND PURIFICATION (2003)
Codon optimization of the HPV-16 E5 gene enhances protein expression
GL Disbrow et al.
VIROLOGY (2003)
Interaction of the HPV E7 proteins with the pCAF acetyltransferase
N Avvakumov et al.
ONCOGENE (2003)
The E5 protein of human papillornavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-γ
BY Zhang et al.
VIROLOGY (2003)
Domain substructure of HPV E6 oncoprotein:: Biophysical characterization of the E6 C-terminal DNA-binding domain
Y Nominé et al.
BIOCHEMISTRY (2003)
HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation
S Weijzen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA
M Yoshinouchi et al.
MOLECULAR THERAPY (2003)
A mutant of human papillomavirus type 16 E6 deficient in binding α-helix partners displays reduced oncogenic potential in vivo
M Nguyen et al.
JOURNAL OF VIROLOGY (2002)
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells
AM Helt et al.
JOURNAL OF VIROLOGY (2002)
Human papillomavirus virus-like particles do not activate langerhans cells: A possible immune escape mechanism used by human papillomaviruses
SC Fausch et al.
JOURNAL OF IMMUNOLOGY (2002)
Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF
SM Huang et al.
JOURNAL OF VIROLOGY (2002)
Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3
A Kumar et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
JS Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins
E Guccione et al.
VIROLOGY (2002)
Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner
SG Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UVB-irradiation-induced apoptosis
BY Zhang et al.
JOURNAL OF VIROLOGY (2002)
Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest
DX Nguyen et al.
JOURNAL OF VIROLOGY (2002)
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes
AM Helt et al.
JOURNAL OF VIROLOGY (2001)
Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7
SL Gonzalez et al.
JOURNAL OF VIROLOGY (2001)
P21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7
F Noya et al.
JOURNAL OF VIROLOGY (2001)
The HPV E7 oncoprotein inhibits tumor necrosis factor α-mediated apoptosis in normal human fibroblasts
DA Thompson et al.
ONCOGENE (2001)
Telomerase activation by human papillomavirus type 16 E6 protein: Induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites
ST Oh et al.
JOURNAL OF VIROLOGY (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene
SC Katich et al.
ONCOGENE (2001)
Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein
A Clements et al.
BIOCHEMISTRY (2000)
Differential regulation of human papillomavirus E6 by protein kinase A:: conditional degradation of human discs large protein by oncogenic E6
C Kühne et al.
ONCOGENE (2000)
Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways
EC Goodwin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins
BA Glaunsinger et al.
ONCOGENE (2000)
Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase
S Nakagawa et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Rapid induction of senescence in human cervical carcinoma cells
EC Goodwin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Oncogenes and tumor angiogenesis:: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
O López-Ocejo et al.
ONCOGENE (2000)
The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle
S Duensing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation
MI Rodríguez et al.
ONCOGENE (2000)
Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes
P Tomakidi et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2000)
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein - Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
p53 regulates the expression of the tumor suppressor gene maspin
ZQ Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-Independent process in stressed human keratinocytes
K Crusius et al.
VIRUS GENES (2000)
Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis
S Song et al.
VIROLOGY (2000)
Share Paper
